Treating transgenic Alzheimer mice with a β-secretase inhibitor, what have we learned?
Jordan Tang1Protein Studies Program, Oklahoma Medical Research Foundation, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, USA, Arun Ghosh2Departments of Chemistry and Medicinal Chemistry, Purdue University, West Lafayette, Indiana, USA
1Protein Studies Program, Oklahoma Medical Research Foundation, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, USA
2Departments of Chemistry and Medicinal Chemistry, Purdue University, West Lafayette, Indiana, USA
Received: January 12, 2011Accepted: January 17, 2011Published: January 17, 2011
